Kodiak Capital Group

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$4.0M
total disclosed, rounds participated
Stages
—

Portfolio · 2

Emerald Medical Application
Platform for Early Detection of Skin Cancer
1 round $1.0M committed Latest: 2016-05
Orgenesis
Cell & Gene Therapy
1 round $3.0M committed Latest: 2013-12

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is Kodiak Capital Group's primary sector focus for investments?
Kodiak Capital Group primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this area.
Can you name some of Kodiak Capital Group's notable portfolio companies?
Kodiak Capital Group's portfolio includes Emerald Medical Application, a platform for early detection of skin cancer, and Orgenesis, a company focused on cell and gene therapy.
Has Kodiak Capital Group had any exits from its portfolio?
Yes, Kodiak Capital Group had an exit in March 2018 when Orgenesis went public on NASDAQ.
What is the typical investment range for Kodiak Capital Group?
Kodiak Capital Group typically invests in the range of $1M - $3M.
When did Kodiak Capital Group make its most recent recorded investment?
Kodiak Capital Group's most recent recorded investment was in May 2016.
What is the business model of Emerald Medical Application, a Kodiak Capital Group portfolio company?
Emerald Medical Application operates with both B2B and B2C business models, offering a platform for early detection of skin cancer.